Chronic lymphocytic leukemia (CLL) is a common leukemia, with a heterogeneous clinical course. When treatment is required, patients usually receive an alkylating agent, such as chlorambucil, or a nucleoside analogue, ...

The clinical course of patients with Chronic Lymphocytic Leukemia (CLL) is highly variable, and identifying genetic abnormalities that lead to aggressive disease is of prognostic and therapeutic importance. Telomere ...